Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report presents two instances where typically irreversible lichen planopilaris and frontal fibrosing alopecia showed signs of hair regrowth and symptom improvement following specific treatments.

This study found that a blackcurrant extract with phytoestrogen activity increased hair number and stem cell marker expression in a menopausal rat model, suggesting a potential benefit for hair loss.

This study found that patients with a greater awareness and understanding of androgenetic alopecia were more likely to seek treatment, suggesting that education may increase treatment willingness.

This article discusses the use of dermoscopy for diagnosing hair and scalp disorders in children and reports no new clinical results.

This letter discusses potential hair loss effects of Hedgehog inhibitors but presents no new clinical findings, urging further exploration of this possible class effect.

This study found that Zizyphus jujuba, especially when fermented with Saccharomyces cerevisiae, showed strong antioxidative activity and effectively promoted hair regrowth and prevented hair loss in a mouse model.

This study describes a novel hairless mutant rat strain, F344-Hr(krh), developed via ENU mutagenesis, which provides a model for skin disease and potentially focal glomerulosclerosis due to specific genetic mutations.

Iron deficiency might cause hair loss, but better testing is needed.

This case report presents the first evidence of significant antigen presenting cells around hair follicles in a patient with alopecia due to active systemic lupus erythematosus.

This case report suggests that lamotrigine treatment may be associated with hair loss as a rare side effect, based on the observation of hair regrowth after discontinuation of the drug in a single patient.

This review discusses the classification and diagnosis of hair loss and emphasizes that nonpermanent alopecia can achieve full regrowth with appropriate treatment, but reports no new results.

This article reviews the causes of hair loss in pediatric and adult populations, emphasizing the importance of distinguishing between primary dermatologic conditions and those related to systemic diseases, but reports no new clinical findings.

This study found that in women irradiated for tinea capitis as children, greater hair loss severity was associated with an increased risk of various mental health issues, particularly social anxiety.

This study suggests that hair loss in Chesapeake Bay retrievers is a breed-specific syndrome characterized by unique histological features and abnormal steroid production, possibly influenced by familial factors.

This study found that telogen effluvium, a type of hair loss, was prevalent among 24% of COVID-19 patients, likely triggered by stress and medication related to the illness.

In this paper, the authors provide recommendations for primary care practitioners on evaluating and treating pediatric hair loss, emphasizing the importance of early diagnosis to prevent permanent scarring alopecia by classifying causes into acquired or congenital origins.

In this study, UCMSC exosomes showed protective effects against cisplatin-induced hearing loss in mice by improving hearing and promoting cochlear tissue repair.

This review discusses the strengths and weaknesses of existing studies on complex dietary supplements for hair loss, emphasizing the need for valid measurement methods like TrichoScale® to quantify effectiveness; it reports no new results.

This study found that a new formulation kit of Pielus Anti-hair loss lotion and shampoo, used daily for 90 days, was safe and effective in reducing hair loss and increasing hair strength and density among patients with telogen effluvium and/or androgenetic alopecia.

This article discusses common underlying mechanisms across hair loss disorders, emphasizing the role of inflammation, but reports no new clinical results.

This abstract contains no research results; it's a website navigation menu and institutional policy information from JAMA Ophthalmology.

This case report suggests that hair loss may be a potential adverse effect of rivaroxaban, though it is not listed in the product characteristics.

This study found that hair loss is common among patients with inflammatory bowel disease, with mesalamine and anti-TNF medications associated with lower odds of experiencing hair loss.

This study observed that the incidence of hair loss as a spontaneously reported side effect of novel oral anticoagulant therapy is approximately 4.4 per 100 patient years.

This commentary critiques the definition of iron deficiency in hair loss studies, suggesting higher serum ferritin levels as a more accurate threshold for diagnosing deficiency in women.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

This report found that hair loss was extremely rare but occurred in some cases with certain antidepressants, notably fluoxetine and 5-HT uptake inhibitors, but not with trazodone or mianserin.

In this study, one-third of men with alopecia androgenetica consulted professionals primarily for hair treatment over two years, valuing medical professionals more for minoxidil-related advice.

This narrative review found that post-COVID-19 hair loss, particularly telogen effluvium, poses a significant mental and social burden, with minoxidil potentially aiding recovery, although more clinical research is needed to confirm its effectiveness.

This article describes the characteristics and management of hypertrichosis induced by low-dose oral minoxidil used for hair disorders, but reports no new clinical findings.